Neurology

One particularly important area where we are placing our Partnering efforts is in Neurology. We believe the field of Neurology is on the cusp of important breakthroughs in both early diagnosis and treatment. Our relentless pursuit of scientific innovation is taking us into areas of enormous unmet medical need and progress in treating diseases of the brain and nervous system.

Our collaborative efforts have resulted in one of the strongest and most diverse pipelines in the industry, spanning the spectrum of nervous system disorders.

Partnering opportunities we are looking for:

  • Neurodegenerative diseases (e.g. Alzheimer's disease, Parkinson's disease, Huntington disease)

  • Neuroinflammation (e.g. Multiple sclerosis)

  • Neuromuscular diseases (e.g. ALS, Duchenne Muscular Dystrophy)

  • Transformational therapies in other CNS indications

Example partnerships

Atalanta TherapeuticsSangamo TherapeuticsInflazomeIonis Pharmaceuticals

Your dedicated partnering leads in Neurology

Tom Zioncheck

Head of Neurology and Ophthalmology, Pharma Partnering

Rose Damestani

Search & Evaluation Lead Neurology, Ophthalmology and Rare Disease, Pharma Partnering

Interested in partnering with us?

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.

Contact our Pharma Partnering Team

More Pharma partnering areas

View all areas

Discover more